S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
Log in

Zimmer Biomet Stock Price, Forecast & Analysis (NYSE:ZBH)

$144.99
-1.79 (-1.22 %)
(As of 11/18/2019 04:00 PM ET)
Today's Range
$144.65
Now: $144.99
$147.52
50-Day Range
$131.19
MA: $137.49
$146.25
52-Week Range
$96.99
Now: $144.99
$147.52
Volume802,752 shs
Average Volume1.17 million shs
Market Capitalization$29.82 billion
P/E Ratio18.98
Dividend Yield0.65%
Beta1.14
Zimmer Biomet Holdings, Inc, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone574-267-6131

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.93 billion
Cash Flow$17.57 per share
Book Value$58.76 per share

Profitability

Net Income$-379,200,000.00

Miscellaneous

Employees19,000
Market Cap$29.82 billion
Next Earnings Date2/7/2020 (Estimated)
OptionableOptionable

Receive ZBH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter.


Zimmer Biomet (NYSE:ZBH) Frequently Asked Questions

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet declared a quarterly dividend on Tuesday, September 3rd. Shareholders of record on Monday, September 30th will be given a dividend of $0.24 per share on Thursday, October 31st. This represents a $0.96 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend is Friday, September 27th. View Zimmer Biomet's Dividend History.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings Inc (NYSE:ZBH) announced its earnings results on Tuesday, November, 5th. The medical equipment provider reported $1.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.02. The medical equipment provider earned $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Zimmer Biomet had a positive return on equity of 13.71% and a negative net margin of 1.14%. The company's revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.63 EPS. View Zimmer Biomet's Earnings History.

When is Zimmer Biomet's next earnings date?

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Friday, February 7th 2020. View Earnings Estimates for Zimmer Biomet.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $7.75 -7.90 for the period, compared to the Thomson Reuters consensus estimate of $7.82. The company issued revenue guidance of flat to +0.5% to ~$7.9-8.3 billion, compared to the consensus revenue estimate of $7.95 billion.

What price target have analysts set for ZBH?

24 analysts have issued 12 month price objectives for Zimmer Biomet's shares. Their forecasts range from $108.00 to $170.00. On average, they expect Zimmer Biomet's share price to reach $147.90 in the next twelve months. This suggests a possible upside of 2.0% from the stock's current price. View Analyst Price Targets for Zimmer Biomet.

What is the consensus analysts' recommendation for Zimmer Biomet?

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 4 hold ratings and 19 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

Has Zimmer Biomet been receiving favorable news coverage?

Media stories about ZBH stock have been trending very negative recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Zimmer Biomet earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Zimmer Biomet.

Who are some of Zimmer Biomet's key competitors?

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include Celgene (CELG), AT&T (T), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Visa (V), General Electric (GE), UnitedHealth Group (UNH), Bristol-Myers Squibb (BMY), Chevron (CVX) and Pfizer (PFE).

Who are Zimmer Biomet's key executives?

Zimmer Biomet's management team includes the folowing people:
  • Mr. Bryan C. Hanson, Pres, CEO & Director (Age 52)
  • Mr. Daniel P. Florin Sr., Exec. VP & CFO (Age 55)
  • Mr. Chad F. Phipps, Sr. VP, Gen. Counsel & Sec. (Age 47)
  • Mr. Sang Yi, Pres of Asia Pacific (Age 57)
  • Mr. Ivan Tornos, Group Pres of Orthopedics (Age 43)

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (5.38%), Wedge Capital Management L L P NC (0.47%), Focused Investors LLC (0.45%), Sumitomo Mitsui Trust Holdings Inc. (0.39%), California Public Employees Retirement System (0.24%) and Schwartz Investment Counsel Inc. (0.24%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

Which major investors are selling Zimmer Biomet stock?

ZBH stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Focused Investors LLC, Wedge Capital Management L L P NC, State of New Jersey Common Pension Fund D, Rothschild Investment Corp IL, Oppenheimer Asset Management Inc., Factory Mutual Insurance Co. and Perpetual Ltd. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

Which major investors are buying Zimmer Biomet stock?

ZBH stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Deroy & Devereaux Private Investment Counsel Inc., Douglas Lane & Associates LLC, Tamarack Advisers LP, Alberta Investment Management Corp, Meeder Asset Management Inc., State of Alaska Department of Revenue and Great Lakes Advisors LLC. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

How do I buy shares of Zimmer Biomet?

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $144.99.

How big of a company is Zimmer Biomet?

Zimmer Biomet has a market capitalization of $29.82 billion and generates $7.93 billion in revenue each year. The medical equipment provider earns $-379,200,000.00 in net income (profit) each year or $7.64 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

What is Zimmer Biomet's official website?

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]


MarketBeat Community Rating for Zimmer Biomet (NYSE ZBH)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  722 (Vote Outperform)
Underperform Votes:  601 (Vote Underperform)
Total Votes:  1,323
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet and other stocks. Vote "Outperform" if you believe ZBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel